← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2013Last known activity
Jun 15, 2021
Timeline
1950s
- Jan 1, 1958
Research Institute for Biological Safety Problems— Founded
Drugs by trial phase (5 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT04930003Study chairPhase 1/Phase 2Jun 15, 2021
- NCT04930003Lead sponsorPhase 1/Phase 2Jun 15, 2021
- NCT04691908Lead sponsorPhase 3Dec 25, 2020
- NCT04530357Study chairPhase 1/Phase 2Sep 19, 2020
- NCT04530357Study directorPhase 1/Phase 2Sep 19, 2020
- NCT04530357Lead sponsorPhase 1/Phase 2Sep 19, 2020
- NCT03572491Lead sponsorPhase 3Sep 18, 2017
- NCT03016143Overall official - principal investigatorPhase 2Oct 1, 2016
- NCT03016143Lead sponsorPhase 2Oct 1, 2016
- NCT03028116Lead sponsorPhase 1May 1, 2016
- NCT03017378Lead sponsorPhase 1Oct 1, 2013
- NCT02501421Lead sponsorPhase 1Oct 1, 2013
- NCT03017378Overall official - principal investigatorPhase 1Oct 1, 2013
Details
- Founded
- Gvardeyskiy, KZ Jan 1, 1958
- Last known activity
- Jun 15, 2021